Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSONG.L Regulatory News (SONG)

  • There is currently no data for SONG

Kepler Trust Intelligence: New Research

24 Feb 2022 07:00

RNS Number : 6126C
Hipgnosis Songs Fund Limited
24 February 2022
 

Hipgnosis Songs: New Research

24/02/2022

SONG has continued to deliver, yet now trades at an attractive discount...

The investment companies team at Kepler Trust Intelligence has produced a new piece of investment bank quality research about the trust, designed to provide a clear and comprehensive reference for long term investors. This note is free to read for UK investors.

Click here to read the note in full.

 

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEASADADXAEFA
Date   Source Headline
14th Dec 202111:08 amRNSDirector/PDMR Shareholding
17th Nov 20217:00 amRNSCapital Markets Day
20th Oct 20214:00 pmRNSChange to Director Roles and Responsibilities
20th Oct 20217:00 amRNSDividend Declaration
12th Oct 202112:01 pmRNSNotice of Capital Markets Day
12th Oct 202112:00 pmRNSBlackstone & Hipgnosis Song Management partnership
15th Sep 202111:20 amRNSResult of AGM
14th Sep 202111:30 amRNSDirector/PDMR Shareholding
17th Aug 20214:30 pmRNSNotice of AGM
9th Aug 20217:00 amRNSAcquisition of Music Catalogue
2nd Aug 20217:00 amRNSTotal Voting Rights
20th Jul 20217:00 amRNSInterim Dividend Announcement
15th Jul 20217:00 amRNSDCMS Committee Report
7th Jul 20216:18 pmRNSPerformance Fee and Total Voting Rights
6th Jul 20216:12 pmRNSResult of Placing
6th Jul 20213:16 pmRNSPublication of Supplementary Prospectus
5th Jul 20217:00 amRNSFinal Results
28th Jun 20217:00 amRNSUpdated Notice of Results
16th Jun 20217:00 amRNSProposed Placing
14th Jun 20212:07 pmRNSDirector/PDMR Shareholding
14th Jun 20217:00 amRNSAppointment of Non-Executive Director
7th Jun 20217:00 amRNSUnaudited NAV, Trading Update & Notice of Results
4th Jun 20217:00 amRNSAcquisition of Music Catalogue
1st Jun 20217:00 amRNSTotal Voting Rights
13th May 20217:00 amRNSAcquisition of Music Catalogue
11th May 20215:48 pmRNSDirector/PDMR Shareholding
5th May 20217:00 amRNSAcquisition of Music Catalogue
30th Apr 20217:00 amRNSResult of Equity Issue
29th Apr 20211:36 pmRNSEquity Issuance Authority
27th Apr 20217:00 amRNSDividend Declaration
1st Apr 20217:00 amRNSConversion to Investment Trust Company
31st Mar 202110:27 amRNSKepler Trust Intelligence: New Research
18th Mar 20217:00 amRNSAcquisition of Music Catalogue
16th Mar 20217:01 amRNSAdditional Performance Disclosure
12th Mar 20211:47 pmRNSDirector/PDMR Shareholding
10th Mar 20217:00 amRNSInvitation to Online Workshop
3rd Mar 20217:00 amRNSAppointment of Executive Vice President
2nd Mar 20214:01 pmRNSDirector/PDMR Shareholding
1st Mar 20217:00 amRNSTotal Voting Rights
26th Feb 20217:00 amRNSOne billion Spotify streams
23rd Feb 202112:30 pmRNSDirector/PDMR Shareholding
23rd Feb 202110:32 amRNSHolding(s) in Company
12th Feb 202111:09 amRNSHolding(s) in Company
10th Feb 20213:36 pmRNSDirector/PDMR Shareholding
5th Feb 20214:26 pmRNSSuccessful Fundraise & Result of EGM
21st Jan 20214:44 pmRNSPublication of Prospectus
21st Jan 20217:00 amRNSLaunch of Issue & Dividend Declaration
21st Jan 20217:00 amRNSAcquisition of Music Catalogue
13th Jan 20217:00 amRNSAcquisition of Music Catalogue
6th Jan 20212:58 pmRNSIncreased Debt Facility

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.